VERA reports Thursday, Nov 5, 2026, after the close. After the last 4 reports the stock moved −4.1%, −2.0%, +1.6%, −1.0% the next day.
VERA is expected to report on Thursday, Nov 5, 2026, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Aug 10, 2026 | -1.59 | -1.52 | −4.1% | +0.2% |
| May 7, 2026 | -1.37 | -1.69 | −2.0% | +7.0% |
| Feb 26, 2026 | -1.27 | -1.39 | +1.6% | −4.9% |
| Nov 5, 2025 | -1.13 | -1.26 | −1.0% | +22.0% |
| Aug 5, 2025 | -0.62 | -1.20 | +0.9% | −1.4% |
| May 6, 2025 | -0.78 | -0.81 | −13.8% | −11.9% |
| Feb 26, 2025 | -0.73 | -0.72 | +2.5% | +5.5% |
| Nov 7, 2024 | -0.62 | -0.85 | — | — |
Average move the next trading day over the last 7 reports: ±3.7% (3 of 7 up).
VERA is in a downtrend, momentum firm. $31.9 is the level overhead; $30 the first support below.
VERA at $30.71. Nearest resistance $31.90 (+3.9%). Nearest support $30.00 (−2.3%).
VERA chart, levels and analysis · Latest analysis: Vera Therapeutics (VERA) stock analysis, October 18, 2026: Post-trial spike has faded and sellers remain in control · Earnings this week
VERA is expected to report on Thursday, Nov 5, 2026, after the close.
VERA reports after the close, US Eastern time.
After its report on Aug 10, 2026, VERA moved −4.1% the next trading day.
Over the last 7 reports, VERA moved 3.7% on average the next trading day, up 3 times out of 7.